• Ensures close connection between patient and physician for remote hypertension monitoring
• Complements Mount Sinai’s growing telehealth initiative
• Medicare-covered and generally at no cost to patients, depending on coverage

LAKE FOREST, IL, and NEW YORK, NY (July 15, 2020) – OMRON Healthcare, Inc., the global leader in personal heart health and wellness technology, and Mount Sinai Health System, New York City’s largest academic medical system, have teamed together to offer patients the new VitalSight™ home blood pressure monitoring solution. Mount Sinai recently rolled out the VitalSight program to support the needs of their patients with hypertension.

“We’re excited to collaborate with such a prestigious healthcare institution as Mount Sinai, who played an instrumental role in shaping the value of VitalSight from early in its development. Now, they are leading the way for patients to use VitalSight from the privacy of their home, while staying closely connected to their physician,” explained OMRON Healthcare President and CEO Ranndy Kellogg.

VitalSight is the newest addition to the comprehensive line of OMRON Healthcare home blood pressure monitors (the #1 doctor and pharmacist recommended brand^1,2) designed to advance the company’s mission of Going for Zero™ — the elimination of heart attack and stroke. The VitalSight kit complements Mount Sinai’s commitment to remotely monitor patients as part of its recent telehealth initiative, especially as providers care for COVID-19 patients who are recovering at home.

The effort to provide VitalSight to patients is led by Dr. Rob Fields, SVP and Chief Medical Officer for Population Health at Mount Sinai, and a dedicated team of clinical pharmacists, who are responsible for the day-to-day management of the program and coordination with physicians to ensure that patients receive individualized care.  “The ability to monitor patients at home during the pandemic – and on an ongoing basis – is critical.  Our collaboration with OMRON Healthcare helps make patients active participants in their own health care and extends the reach of clinicians, who receive a continuous stream of their patients’ real-time health data so that they can proactively intervene as necessary,” he said.  “Additionally, we are focusing first on our most vulnerable patients, who bear the consequences of disparities in care – in part, due to lack of technology access. This program requires no technology and comes at no cost for the device, with little-to-no cost for service.”

VitalSight is a HIPAA-compliant, Medicare-reimbursable home blood pressure monitoring solution that generally comes at no cost to the patient, depending on their coverage. The kit typically includes a digital blood pressure monitor with cuff, weight scale and digital medication tracker, as well as a data hub.  Exact devices may vary based on what the physician deems appropriate for each patient’s hypertension monitoring needs. VitalSight directly links to a physician’s Electronic Medical Record (EMR), and is compatible with leading systems. Patients measure their blood pressure, weigh themselves and continue to take their medication as ordered by their physician. Securely encrypted data is automatically sent to the doctor’s EMR in real time, where it’s stored for reference unless a health concern is detected, in which case the physician’s office is alerted.

For more information, please visit www.omronhealthcare.com and www.mountsinai.org.

About OMRON Healthcare, Inc.
OMRON Healthcare, Inc., is the world’s leading manufacturer and distributor of personal heart health and wellness products. Its market-leading products include a full-range of home blood pressure monitors and pain management devices. Since OMRON invented its first blood pressure monitors more than 40 years ago, the company has been passionate about empowering people to take charge of their health at home through precise technology. OMRON is the number one doctor and pharmacist recommended brand of blood pressure monitors for home use. The company’s mission is Going for Zero, the elimination of heart attacks and strokes. For more information, visit OmronHealthcare.com and follow OMRON Healthcare on Facebook, Twitter and LinkedIn.

About the Mount Sinai Health System
The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.  For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Media Contact
Jodi Perkins
Outlook Marketing Services, Inc.
[email protected]
(847) 508-0877

1. Frost & Sullivan Survey, Blood pressure clinician perception tracker surveys. 17 July 2019.
2. U.S. News Staff 2019, U.S. News & World Report, accessed 8 August 2019.